Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy

Jul 31, 2026

Update on Phase III trial of Ultomiris in adults and adolescents with thrombotic microangiopathy after haematopoietic stem cell transplant

Jul 27, 2026

Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers

Jul 27, 2026

H1 and Q2 2026 results

Jul 27, 2026

Enhertu plus pertuzumab recommended for approval in the EU by CHMP as 1st-line treatment for patients with HER2-positive metastatic breast cancer

Jul 24, 2026

Trixeo recommended for approval in the EU by CHMP for the maintenance treatment of asthma

Jul 24, 2026

From official company newsrooms and press releases.

About AstraZeneca

Claim to unlock

Company description, mission, culture, and benefits — visible after this page is claimed and verified.

Find Your Role at AstraZeneca

Search AstraZeneca Jobs

← Browse all companies

Profile generated from publicly available hiring data.

·Are you AstraZeneca? Claim this page or contact us